Oral News and Research

RSS

Pediatric cancer diagnosis can take a significant toll on financial well-being of families

Almost one-third of families whose children were being treated for cancer faced food, housing or energy insecurity and one-quarter lost more than 40 percent of household income, according to a new study from Dana-Farber/Boston Children's Cancer and Blood Disorders Center.

26 Sep 2015

Novo Nordisk announces FDA approval of Tresiba (insulin degludec injection) for diabetes treatment

Novo Nordisk, a world leader in diabetes care, today announced that the U.S. Food and Drug Administration approved the new drug application for Tresiba (insulin degludec injection), a once-daily, long-acting basal insulin. Tresiba is indicated for use alone, or in combination with oral antidiabetic medicines or bolus insulin, and is approved for glycemic control in adults with type 1 and type 2 diabetes. Tresiba provides a long duration of action beyond 42 hours.

From Novo Nordisk 26 Sep 2015

Weight loss and exercise improve ovulation in women with polycystic ovary syndrome

Weight loss and exercise improve ovulation in women who have polycystic ovary syndrome, a common hormone disorder that often causes infertility, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

25 Sep 2015

Stanford researchers successfully defeat C. difficile bacteria

Stanford University School of Medicine scientists successfully defeated a dangerous intestinal pathogen, Clostridium difficile, with a drug targeting its toxins rather than its life.

24 Sep 2015

FDA approves LONSURF for treatment of patients with metastatic colorectal cancer

Taiho Oncology, Inc. (U.S.), a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), today announced that the U.S. Food and Drug Administration approved LONSURF (trifluridine and tipiracil), formerly known as TAS-102, for the treatment of patients with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF biological therapy, and if RAS wild-type, an anti-EGFR therapy.

22 Sep 2015

$Bisphosphonate drugs linked to greater risk of atypical hip fractures$

Bisphosphonate drugs linked to greater risk of atypical hip fractures

The use of bisphosphonates, a group of drugs used to prevent hip breakages in women with osteoporosis, is associated with an increased risk of atypical fractures in this joint, understood as those that occur in less frequent locations.

22 Sep 2015

UIC to develop and test outreach program to improve children’s oral health in Chicago

The University of Illinois at Chicago will develop and test an outreach program to reduce cavities in Chicago's low-income and minority infants and toddlers under a five-year, $5 million grant from the National Institutes of Health.

22 Sep 2015

$Common Alzheimer's disease drug increases bone density, reduces fracture risks$

Common Alzheimer's disease drug increases bone density, reduces fracture risks

The most common drug used to treat Alzheimer's disease increases bone mass in mice, according to one of the first research articles published in the new open access journal Heliyon. The authors of the study, from Saitama Medical University in Japan, say this means the drug could also be used to treat bone loss diseases like osteoporosis and periodontitis, following further clinical research.

21 Sep 2015

Report: Birth control pills cause significant increase in stroke risk

Birth control pills cause a small but significant increase in the risk of the most common type of stroke, according to a comprehensive report in the journal MedLink Neurology.

21 Sep 2015

Combination of TXA709 and cefdinir demonstrates synergistic antibacterial activity against MRSA

TAXIS Pharmaceuticals, a drug-discovery company focused on developing a new class of antibiotic agents to treat life-threatening, multidrug-resistant bacterial infections, announced the presentation of results demonstrating the synergistic antibacterial activity of its lead clinical candidate, TXA709, when combined with cefdinir, a third-generation cephalosporin antibiotic.

19 Sep 2015

Researchers identify new way to predict effectiveness of chemotherapy in head and neck cancer patients

Manchester researchers have identified a potential new way to predict which patients with head and neck cancer may benefit most from chemotherapy.

18 Sep 2015

Acute Cardiovascular Care 2015 to be held in Vienna from 17 to 19 October

Acute Cardiovascular Care 2015 will highlight innovations and controversies in the field, guaranteeing great stories on topics relevant to the press.

18 Sep 2015

ACCC survey highlights challenges and recent trends in U.S. cancer programs

The Association of Community Cancer Centers (ACCC) recently released results of its sixth annual Trends in Cancer Programs survey, highlighting the challenges and recent trends seen in U.S. cancer programs.

18 Sep 2015

Blue Cross plans to offer dental products in 2016

Blue Cross and Blue Shield of Minnesota today announced plans to offer dental products in 2016, the result of a new agreement with Pennsylvania-based United Concordia Dental.

15 Sep 2015

School meals paired with popular vegetables less likely to wind up in waste bins

A study led by a team of Texas A&M University System researchers found school meals paired with popular vegetables are less likely to wind up in garbage bins.

15 Sep 2015

Better treatment could be on the horizon for Myasthenia Gravis

Myasthenia Gravis (MG) is a debilitating and potentially deadly disease that can afflict anyone, characterized by severe muscle weakness, affecting control of facial expressions, arm and leg movements, chewing, swallowing, coughing and breathing. There is no cure, only treatment.

14 Sep 2015

ULURU signs definitive agreement to sell common stock to European investors

ULURU Inc., a specialty pharmaceutical company focused on the development of a portfolio of wound management and oral care products, today announced the signing of a definitive agreement to sell an aggregate of 4,079,539 shares of its common stock at a price per share of $0.38 to a group of European investors, which is expected to result in gross proceeds of $1,550,225.

11 Sep 2015

Aspen Dental opens new office in Richmond, Kentucky

A new Aspen Dental is opening in Richmond, Kentucky on Thursday, September 17. Located at 1072 Barnes Mill Road, the conveniently-located practice will provide dental services that range from dentures and preventive care to general dentistry and restoration.

11 Sep 2015

FGF21 compound in breast milk plays key role in neonatal nutrient absorption, intestinal function

A compound found in breast milk, named fibroblast growth factor 21 (FGF21), plays a key role in neonatal nutrient absorption and intestinal function. FGF21 also contributes to improve newborn growth and metabolic profile.

11 Sep 2015

ACR releases two new publications to improve treatment of polymyalgia rheumatica, gout

The American College of Rheumatology (ACR) has released two new publications - recommendations aimed at improving the treatment of patients with polymyalgia rheumatica (PMR), and new classification criteria for gout.

10 Sep 2015

Oral News and Research

Pediatric cancer diagnosis can take a significant toll on financial well-being of families

Novo Nordisk announces FDA approval of Tresiba (insulin degludec injection) for diabetes treatment

Weight loss and exercise improve ovulation in women with polycystic ovary syndrome

Stanford researchers successfully defeat C. difficile bacteria

FDA approves LONSURF for treatment of patients with metastatic colorectal cancer

Bisphosphonate drugs linked to greater risk of atypical hip fractures

UIC to develop and test outreach program to improve children’s oral health in Chicago

Common Alzheimer's disease drug increases bone density, reduces fracture risks

Report: Birth control pills cause significant increase in stroke risk

Combination of TXA709 and cefdinir demonstrates synergistic antibacterial activity against MRSA

Researchers identify new way to predict effectiveness of chemotherapy in head and neck cancer patients

Acute Cardiovascular Care 2015 to be held in Vienna from 17 to 19 October

ACCC survey highlights challenges and recent trends in U.S. cancer programs

Blue Cross plans to offer dental products in 2016

School meals paired with popular vegetables less likely to wind up in waste bins

Better treatment could be on the horizon for Myasthenia Gravis

ULURU signs definitive agreement to sell common stock to European investors

Aspen Dental opens new office in Richmond, Kentucky

FGF21 compound in breast milk plays key role in neonatal nutrient absorption, intestinal function

ACR releases two new publications to improve treatment of polymyalgia rheumatica, gout

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News